FTXH

Fund Description
The First Trust Nasdaq Pharmaceuticals ETF is an exchange-traded fund. The investment objective of the Fund is to seek investment results that correspond generally to the price and yield, before fees and expenses, of an equity index called the Nasdaq US Smart Pharmaceuticals Index. The Nasdaq US Smart Sector Index Family tracks a number of United States (US) economic sectors and selects securities for each sector based upon liquidity and then ranks the securities based on a three factor methodology incorporating volatility, value and growth. The Nasdaq US Smart Sector Index Family is a modified factor weighted index. The value of the Index equals the aggregate value of the Index share weights, also known as the Index Shares, of each of the Index Securities multiplied by each such security s Last Sale Price, and divided by the divisor of the Index. The divisor serves the purpose of scaling such aggregate value to a lower order of magnitude which is more desirable for reporting purposes. The Indexes began on July 8, 2016 at a base value of 1000. Index eligibility is limited to specific security types only. The security types eligible for the Index include common stocks, ordinary shares, depositary receipts (both American and Global), depositary shares, shares of beneficial interest or limited partnership interests and tracking stocks.
Fund Profile
Fund Name First Trust Nasdaq Pharmaceuticals ETF
Fund Exchange Ticker FTXH
Fund Sponsor First Trust
Fund ISIN US33738R8372
Net Expense Ratio 0.60 %
Fund Inception Date 20 September 2016
Fund Legal Structure ETF (Open end fund)
Exchange NASDAQ
Listing Country Code US
Fund Investment Objective
ETF Type Specific US Equities - Industry Sector
Asset Class Equities (Stocks)
Index Linked Passive
Index Name Nasdaq US Smart Pharmaceuticals Index
Index Provider Nasdaq
Currency Hedged No
Inverse / Leveraged Not Applicable
Developed / Emerging Developed Market Funds
Market Capitalization Range Broad Market / Multi-Cap
Growth Value Core / Blend
Continent North America
Key Statistics
Return As of Date 22 January 2021
Asset Under Management 21.28 Million (USD)
1 Month Total Return 4.92 %
Year To Date Return 3.36 %
1 Year Total Return 12.44 %
3 Year Annualized Total Return 6.60 %
NAV 26.6
Share Outstanding 800,002
Top 10 Holdings (22 January 2021)
Constituent Name Constituent Ticker Constituent Type Weighting
JOHNSON & JOHNSON JNJ EQUI 0.0847530762
ABBVIE INC ABBV EQUI 0.0794845988
BRISTOL-MYERS SQUIBB CO BMY EQUI 0.0775788383
MERCK & CO. INC. MRK EQUI 0.0755346901
PFIZER INC PFE EQUI 0.0715390270
ELI LILLY & CO LLY EQUI 0.0530680803
CATALENT INC CTLT EQUI 0.0455523970
JAZZ PHARMACEUTICALS PLC JAZZ EQUI 0.0449297365
HORIZON THERAPEUTICS PLC HZNP EQUI 0.0413793038
PRESTIGE CONSUMER HEALTHCARE PBH EQUI 0.0401357235